Bioactive Toxin-Derived Peptides Antimicrobial & Antimycotic Peptides Custom Research Peptides Nuclear Localization Signals (NLS) Cell-Penetrating Peptides (CPPs) Alzheimer's & Parkinson's Therapeutic Development Melanogenesis Modulation Anti-Aging & Skin Remodeling Ligand-Directed Targeting Peptides Somatostatin Analogs Kinase Activity Modulators Apoptotic Enzymes Viral Protease Substrates Antiviral Peptides Antimicrobial Peptides Cardiovascular Peptides Immunomodulatory Peptides Thyroid Hormone-Related Insulin/Metabolic Regulation Parathyroid Hormone (PTH) Growth Hormone GnRH Analogues/Antagonists Pain and Inflammation Modulation Pituitary Hormones Neurotransmitters/Neuropeptides Standard Fmoc-Amino Acids D-Form Amino Acids Resins Condensation Agents Organic Building Blocks Pseudoproline Dipeptides Phenylalanine & Tryptophan Unusual Amino Acids & Analogs Newly Launched Small-Molecule Specialties Impurity Analysis & Bioactivity Research Special Offers Peptide Synthesis Chemical Synthesis ADMET Profiling Service AlanMolecularAI AlanDockAI Linear Peptide Optimization Cyclic Peptide Optimization Task Management Knowledge Center News About Us Reagents & Custom Orders Aipower Platform
Sign in
Cart
Search
Home Product Peptide Catalog Products Alzheimer's & Parkinson's Therapeutic Development Non-Ab Component of Alzheimer's Disease Amyloid

DESCRIPTION

Non-Aβ Component of Alzheimer's Disease Amyloid refers to the diverse array of non-amyloid β (Aβ) molecules and proteins that coexist with Aβ peptides in the amyloid plaques of Alzheimer’s disease (AD) brains. These components include tau protein (forming neurofibrillary tangles), apolipoprotein E (APOE), α-synuclein, complement factors, prion proteins, and various cellular and vascular elements. Unlike Aβ, which is the primary structural component of plaques, non-Aβ constituents modulate plaque formation, stability, and neurotoxicity, often interacting with Aβ to enhance aggregation, inflammation, or synaptic dysfunction. For example, tau pathology synergizes with Aβ to drive neurodegeneration, while APOE influences Aβ clearance and deposition. Studying these components is critical for understanding the complex interplay of molecular pathways in AD, as they contribute to disease progression, therapeutic resistance, and phenotypic variability. By characterizing their roles in plaque biology and cross-talk with Aβ, researchers aim to develop more comprehensive strategies targeting the multifaceted nature of Alzheimer’s pathology, beyond single-component interventions.

Chemical Formula: C141H235N39O49

Molecular Weight: 3260.68

Sequence: Glu-Gln-Val-Thr-Asn-Val-Gly-Gly-Ala-Val-Val-Thr-Gly-Val-Thr-Ala-Val-Ala-Gln-Lys-Thr-Val-Glu-Gly-Ala-Gly-Ser-Ile-Ala-Ala-Ala-Thr-Gly-Phe-Val

Purity: From crude to 98%

If there are no products available iwth the required purity and quantity, please inform us of your specifications and send an email to sales@alanscientific.com

Our representitives will respond within 24 hours

Research Use Only

Non-Ab Component of Alzheimer's Disease Amyloid

Catalog No: AS2713

{{ getShowPrice() }} {{ getPrice() }}

Add to Cart Bulk Inquiry
{{ isCollect ? 'Cancel collection' : 'Collection' }}

Related Products

Submit